The Detection of the Herpesvirus of Bovine Malignant Catarrhal Fever in Rabbit Lymphocytes in vivo and in vitro

References

1. Biggs P. M. 1968; Marek’s disease-current state of knowledge. Current Topics in Microbiology and Immunology 43:92–125
   [Google Scholar]
2. Campbell J. G., Woode G. N. 1970; Demonstration of a herpes-type virus in short-term cultured blood lymphocytes associated with Marek’s disease. Journal of Medical Microbiology 3:463–473
   [Google Scholar]
3. Daubney R., Hudson J. R. 1936; Transmission experiments with bovine malignant catarrh. Journal of Comparative Pathology and Therapeutics 49:63–89
   [Google Scholar]
4. Dougherty R. M. 1964 In Techniques in Experimental Virology pp 161–183 Edited by Harris R. C. London, New York: Academic Press;
   [Google Scholar]
5. Edington N., Patel J., Russell P. H., Plowright W. 1979; The nature of the acute lymphoid proliferation in rabbits infected with the herpesvirus of bovine malignant catarrhal fever. European Journal of Cancer 16: (in the press)
   [Google Scholar]
6. Epstein M. A. 1975; Transformation in vivo- A Review. In Oncogenesis and Herpesviruses II IARC Scientific Publications No 11 part 2 pp 141–151 Edited by de The G., Epstein M. A., Zur Hausen H. Lyon: IARC;
   [Google Scholar]
7. Epstein M. A., Achong B. G. 1977; Recent progress in Epstein-Barr virus research. In Annual Review of Microbiology vol 31 pp 421–445 Edited by Starr M. P., Ingraham J. L., Balows A. Palo Alto, California: Annual Reviews Inc;
   [Google Scholar]
8. Epstein M. A., Achong B. G., Barr Y. M. 1964; Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1:702–703
   [Google Scholar]
9. Falk L. A., Wolfe L. G., Hoekstra J., Deinhardt F. 1972; Demonstration of herpesvirus saimiri- associated antigens in peripheral lymphocytes from infected marmosets during in vitro cultivation. Journal of the National Cancer Institute 48:523–529
   [Google Scholar]
10. Falk L. A., Wright J., Wolfe L., Deinhardt F. 1974; Herpesvirus ateles: transformation in vitro of marmoset splenic lymphocytes. International Journal of Cancer 14:244–251
    [Google Scholar]
11. Ford W. L., Hunt S. V. F. 1973; The preparation and labelling of lymphocytes. In Handbook of Experimental Immunology pp 23.1–23.27 Edited by Weir D. M. Oxford, London, Edinburgh, Melbourne: Blackwell Scientific Publications;
    [Google Scholar]
12. Frazier J. A. 1974; Ultrastructure of lymphoid tissues from chickens infected with Marek’s disease virus. Journal of the National Cancer Institute 52:829–837
    [Google Scholar]
13. Gergely L., Klein G., Ernberg I. 1971; The action of DNA antagonists on Epstein-Barr virus (EBV)-associated early antigen (EA) in Burkitt lymphoma lines. International Journal of Cancer 7:293–302
    [Google Scholar]
14. Giddens W. E. Jun 1975; Ultrastructural and immunofluorescent studies of the replication of herpesvirus saimiri in cultured lymphocytes of infected owl monkeys. In Oncogenesis and Herpesviruses II. IARC Scientific Publications No 11 part 2 pp 113–119 Edited by de The G., Zur Hausen M. A. H. Lyon: IARC;
    [Google Scholar]
15. Herbert W. J. 1973; Mineral-oil adjuvants and the immunization of laboratory animals. In Handbook of Experimental Immunology appendix 2 Edited by Weir D. M. Oxford, London, Edinburgh. Melbourne: Blackwell Scientific Publications;
    [Google Scholar]
16. Hudson L., Hay F. C. 1976 In Practical Immunology Oxford, London, Edinburgh, Melbourne: Blackwell Scientific Publications;
    [Google Scholar]
17. Lee L. F., Nazerian K., Boezi J. A. 1975; Marek’s disease virus DNA in a chicken lymphoblastoid cell line (MSB-1) and in virus-induced tumors. In Oncogenesis and Herpesviruses II. IARC Scientific Publications No 11 part 2 pp 199–204 Edited by de The G. Epstein M. A., Zur Hausen H. Lyon: IARC;
    [Google Scholar]
18. Morgan C., Rose H. M. 1967; The application of thin sectioning. In Methods in Virology vol III pp 576–614 Edited by Maramorosch K., Koprowski H. New York, London: Academic Press;
    [Google Scholar]
19. Nairn R. C. 1976 In Fluorescent Protein Tracing pp 369–372 Edited by Nairn R. C. Edinburgh: Churchill Livingstone;
    [Google Scholar]
20. Plowright W., Ferris R. D., Scott G. R. 1960; Blue wildebeest and the aetiological agent of bovine malignant catarrhal fever. Nature, London 188:1167–1169
    [Google Scholar]
21. Plowright W. 1968; Malignant catarrhal fever. Journal of the American Veterinary Medical Association 152:795–804
    [Google Scholar]
22. Powell P. C., Payne L. N., Frazier J. A., Rennie M. 1975; T. lymphoblastoid cell lines from Marek’s disease lymphomas. In Oncogenesis and Herpesviruses II. IARC Scientific Publications No 11 part 2 pp 89–100 Edited by de The G. Epstein M. A., Zur Hausen H. Lyon: IARC;
    [Google Scholar]
23. Reid H. W., Plowright W., Rowe L. W. 1975; Neutralizing antibody to herpesvirus derived from wildebeest and hartebeest in wild animals in East Africa. Research in Veterinary Science 18:269–273
    [Google Scholar]
24. Reedman B. M., Klein G. 1973; Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Journal of the National Cancer Institute 11:499–520
    [Google Scholar]
25. Ross L. J. N., Powell P. C., Walker D. J., Rennie M., Payne L. N. 1977; Expression of virus-specific, thymus-specific and tumour-specific antigens in lymphoblastoid cell lines derived from Marek’s disease lymphomas. The Journal of General Virology 35:219–235
    [Google Scholar]
26. Rossiter P. B., Mushi E. Z., Plowright W. 1977; The development of antibodies in rabbits and cattle infected experimentally with an African strain of malignant catarrhal fever virus. Veterinary Microbiology 2:57–66
    [Google Scholar]
27. Rossiter P. B., Mushi E. Z., Plowright W. 1978; Antibody response in cattle and rabbits to early antigens of malignant catarrhal fever virus in cultured cells. Research in Veterinary Science 25:207–210
    [Google Scholar]
28. Wenger D. L., Hinze H. C. 1974; Virus-host-cell relationship of herpesvirus sylvi/agus with cottontail rabbit leukocytes. International Journal of Cancer 14:567–575
    [Google Scholar]